AUTONOMIX MEDICAL, INC. Proceeds from Convertible Debt
AUTONOMIX MEDICAL, INC. (AMIX) reported Proceeds from Convertible Debt of $0 for the 3-month period ending 2025-03-31, per its 10-K filed 2025-05-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2025-05-29
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for the quarter ending 2024-03-31 was $2.00M.
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for the quarter ending 2023-12-31 was $1.65M.
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for fiscal 2024 was $2.00M.
- AUTONOMIX MEDICAL, INC. proceeds from convertible debt for fiscal 2023 was $0.00.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-05-29 | $0.00 derived: sum of 2 quarters · filed 2025-05-29 | ||
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2024-03-31 | $2.00M 10-K · filed 2025-05-29 | $3.65M derived: sum of 2 quarters · filed 2025-05-29 | $2.00M 10-K · filed 2024-05-31 | |
| 2023-12-31 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $2.00M 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | $350.00K 10-Q · filed 2024-11-08 | |||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $0.00 10-K · filed 2024-05-31 | ||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |